News US bill paints some Chinese biotechs as security threats Legislation tabled in the US is seeking to block Chinese life sciences companies from claiming federal funding and contracts on the grounds they are a national security co
News WuXi to build new $60m clinical and manufacturing plant WuXi Biologics has pledged to invest $60 million into a new US-based site to expand its clinical and manufacturing arm.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face